UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Responder analyses and the assessment of a clinically relevant treatment effect

Trials, 2007-10, Vol.8 (1), p.31-31, Article 31

2007

Volltextzugriff (PDF)

A shrinkage estimator for subgroup analysis without the exchangeability assumption

Journal of biopharmaceutical statistics, 2021-11, Vol.31 (6), p.723-735

Snapinn, Steven

2021

Volltextzugriff (PDF)

Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier Estimator

The American statistician, 2005-11, Vol.59 (4), p.301-307

2005

Volltextzugriff (PDF)

Noninferiority trials

Trials, 2000-07, Vol.1 (1), Article 19

Snapinn, Steven M

2000

Volltextzugriff (PDF)

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study

Kidney international, 2003-04, Vol.63 (4), p.1499-1507

2003

Volltextzugriff (PDF)

Statins for Secondary Prevention of Cardiovascular Disease: The Right Dose

Pharmacology, 2011-01, Vol.87 (1-2), p.63-69

2011

Volltextzugriff (PDF)

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Journal of hypertension, 2002-09, Vol.20 (9), p.1879-1886

2002

Volltextzugriff (PDF)

Alternatives for Discounting in the Analysis of Noninferiority Trials

Journal of biopharmaceutical statistics, 2004-12, Vol.14 (2), p.263-273

Snapinn, Steven M.

2004

Volltextzugriff (PDF)

Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies

The American journal of cardiology, 2005-12, Vol.96 (11), p.1530-1536

2005

Volltextzugriff (PDF)

Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: Angiographic results from the PRISM-PLUS Trial (platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms)

Circulation (New York, N.Y.), 1999-10, Vol.100 (15), p.1609-1615

1999

Volltextzugriff (PDF)

Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy : The losartan intervention for endpoint (LIFE) reduction in hypertension study

Circulation (New York, N.Y.), 2006-03, Vol.113 (12), p.1588-1596

2006

Volltextzugriff (PDF)

Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients

Hypertension (Dallas, Tex. 1979), 2004-07, Vol.44 (1), p.48-54

2004

Volltextzugriff (PDF)

Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study

Hypertension (Dallas, Tex. 1979), 2005-01, Vol.45 (1), p.46-52

2005

Volltextzugriff (PDF)

Benefits and safety of tirofiban among acute coronary Syndrome patients with mild to moderate renal insufficiency: Results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in patients limited by Unstable Signs and Symptoms (PRISM-PLUS) trial

Circulation (New York, N.Y.), 2002-05, Vol.105 (20), p.2361-2366

2002

Volltextzugriff (PDF)

Sex-based short- and long-term survival in patients following complicated myocardial infarction

European heart journal, 2006-09, Vol.27 (18), p.2177-2183

2006

Volltextzugriff (PDF)

Correlation between the TIMI risk score and high-risk angiographic findings in non–ST-elevation acute coronary syndromes: Observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial

The American heart journal, 2005-05, Vol.149 (5), p.846-850

2005

Volltextzugriff (PDF)

Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy

Hypertension (Dallas, Tex. 1979), 2005-04, Vol.45 (4), p.580-585

2005

Volltextzugriff (PDF)

Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: Insights from the PRISM-PLUS study

International journal of cardiology, 2005-04, Vol.100 (1), p.73-78

2005

Volltextzugriff (PDF)

Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension : the RENAAL and LIFE studies

Journal of hypertension, 2007-04, Vol.25 (4), p.871-876

2007

Volltextzugriff (PDF)

The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study

Journal of the American College of Cardiology, 2005-09, Vol.46 (5), p.770

2005

Volltextzugriff (PDF)

Patient-Identified Most Bothersome Symptom in Patients with Chronic Migraine: An Analysis of PROMISE-2 (541)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Withdrawal of statins increases event rates in patients with acute coronary syndromes

Circulation (New York, N.Y.), 2002-03, Vol.105 (12), p.1446-1452

2002

Volltextzugriff (PDF)

Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial

The American journal of cardiology, 2004-04, Vol.93 (7), p.843-847

2004

Volltextzugriff (PDF)

Pure and Hybrid Causal Effects on Variables Associated with an Incident Event

Journal of biopharmaceutical statistics, 2013-07, Vol.23 (4), p.719-729

2013

Volltextzugriff (PDF)

Informative noncompliance in endpoint trials

Current controlled trials in cardiovascular medicine, 2004-07, Vol.5 (1), Article 5

2004

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(76)
Reviews
(1)

Sprache

Englisch
(77)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Responder analyses and the assessment of a clinically relevant treatment effect

A shrinkage estimator for subgroup analysis without the exchangeability assumption

Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier Estimator

Noninferiority trials

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study

Statins for Secondary Prevention of Cardiovascular Disease: The Right Dose

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Alternatives for Discounting in the Analysis of Noninferiority Trials

Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies

Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy : The losartan intervention for endpoint (LIFE) reduction in hypertension study

Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients

Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study

Benefits and safety of tirofiban among acute coronary Syndrome patients with mild to moderate renal insufficiency: Results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in patients limited by Unstable Signs and Symptoms (PRISM-PLUS) trial

Sex-based short- and long-term survival in patients following complicated myocardial infarction

Correlation between the TIMI risk score and high-risk angiographic findings in non–ST-elevation acute coronary syndromes: Observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial

Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy

Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: Insights from the PRISM-PLUS study

Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension : the RENAAL and LIFE studies

The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study

Patient-Identified Most Bothersome Symptom in Patients with Chronic Migraine: An Analysis of PROMISE-2 (541)

Withdrawal of statins increases event rates in patients with acute coronary syndromes

Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial

Pure and Hybrid Causal Effects on Variables Associated with an Incident Event

Informative noncompliance in endpoint trials

Aktive Filter

Suchergebnisse filtern